PAE (517230)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹4.7 |
| Market Cap | ₹0.47 Cr |
| P/E Ratio | 0.09 |
| ROCE | 0% |
| ROE | -47.06% |
| Dividend Yield | 0% |
| Profit Growth | -15.38% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹0.99 — ₹65.71 |
| Sector | Auto Components |
Strengths
- Auto components is a core segment of the Indian manufacturing ecosystem, so any genuine revival in operations would have an industry tailwind.
- The stock at ₹4.70 trades about 93% below its 52-week high of ₹65.71, implying a large part of the decline may already be reflected.
- The reported P/E of 0.09 is optically cheap, though it appears inconsistent with the negative ROE and needs verification.
- The latest quarterly net loss is negligible in rupee terms at ₹-0 Cr, so a modest improvement in sales could produce a swing to profitability.
Concerns
- ROE of -47.06% and ROCE of 0.00% show severe capital destruction and no return on invested capital.
- Latest quarter sales of ₹0 Cr and sales growth of 0.00% indicate no revenue engine, while profit growth is -15.38%.
- Piotroski F-Score of 2/9 signals very weak financial health; book value, debt/equity, and promoter holding are all N/A, so transparency is poor.
- The extreme 52-week range of ₹0.99-₹65.71 and a market cap shown as ₹0 Cr raise concerns about price stability, liquidity, and data reliability.
AI Analysis
At first glance, a P/E of 0.09 looks like the cheapest stock on the exchange. But I have learned to be suspicious when something appears this cheap. PAE is classified under auto components, an industry that can offer steady demand but is also cyclical and capital-hungry. The company itself, however, is not demonstrating a working, profitable business. Latest quarterly sales are ₹0 Cr, and net profit is ₹-0 Cr. Sales growth is flat at 0.00%, while profit growth is negative at -15.38%. Return on equity is -47.06%, and ROCE is 0.00%. A business earning no return on capital and destroying shareholder equity is not a compounder; it is a candidate for distress. The Piotroski F-Score of 2/9 confirms poor fundamental health. Book value is N/A, debt/equity is N/A, and promoter holding is N/A, so I cannot calculate margin of safety or even assess owner alignment. Market capitalisation is shown as ₹0 Cr; that makes me question liquidity and reliability of the quoted price. The 52-week range of ₹0.99 to ₹65.71 is a red flag, not an opportunity: a stock can fall from ₹65.71 to ₹4.70 because something is seriously wrong. There is no dividend yield, no positive growth, and no evidence of a moat. Graham would reject it because the facts do not support a tangible asset value. Buffett would reject it because quality and returns on capital are absent. The only reason to study this further would be a potential turnaround, but a turnaround needs visible operational improvement, not just a low price. I will wait for positive quarterly sales, positive cash flow, and a credible plan. Until then, this belongs in the too-hard pile.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer